Skip to main content
. Author manuscript; available in PMC: 2009 Nov 27.
Published in final edited form as: J Biopharm Stat. 2008;18(6):1084–1102. doi: 10.1080/10543400802369012

Table 4.

Percentage of data sets simulated under H1 with N = 40 for which each model is selected.

Method Algorithm K Model1
Mbase Mrecessive Mdominant Mmult
ANOVA FO 995 25.5 44.8 21.0 8.7
FOCE 968 22.3 43.3 25.5 8.9

Wald FOCE 878 17.9 41.7 32.7 7.7

LRT FOCE 923 19.1 47.3 20.5 13.1

AIC FOCE 962 1.3 31.1 13.1 54.5

AICc FOCE 962 1.6 35.1 14.7 48.6

CAIC FOCE 962 28.1 48.5 19.9 3.5

BIC FOCE 962 21.6 50.3 21.7 6.4

BICc FOCE 962 11.5 51.7 33.1 13.7

K is the number of data sets on which the test could be performed.

1

Mbase: {β0 = β1 = β2 = 1} (CC=CT=TT) model with no gene effect.

Mrecessive: {β0 = β1 = 1, β2 ≠ 1} (CC = CT ≠ TT), reduced model.

Mdominant: {β0 = 1, β1 = β2 ≠ 1} (CC ≠ CT = TT), reduced model.

Mmult: {β0 = 1, β1β2 ≠ 1} (CC ≠ CT ≠ TT), complete model.

Results obtained with FO are not presented for these strategies because of their poor performance under H0 (table 3).